CONGENITAL HYPERTHYROIDISM CASE REPORT
|
|
- Brandon Bell
- 5 years ago
- Views:
Transcription
1 CASE REPORTS CONGENITAL HYPERTHYROIDISM CASE REPORT Ioana Micle 1,2, Elena Pop 2, Ramona Giurescu 1, Daniela Cioboata 2, Monica Marazan 1,2, Alina Corneli 2 REZUMAT Introducere: Hipertiroidismul neonatal apare la nou-născutii din mame cu boală tiroidiană autoimună. Frecvența bolii este de aproximativ 1-5% din copii mamelor cu boală Graves-Basedow. Gravitatea simptomatologiei este data de titrul de anticorpi ce traverseaza placenta. Scopul lucrării: Sublinierea problemelor de diagnostic şi a complicaţiilor care pot să apară în absenţa unei atente monitorizări a unui nou-născut provenit dintr-o mamă cu boală Graves-Basedow. Material și metode: Autorii prezintă cazul unui nou- nascut de 2 săptămani, din mamă cu boala Basedow, internat in clinică pentru agitatie, tulburari de circulatie periferica, icter, retardul creşterii. In urma unei evaluări clinice, paraclinice, imunologice si hormonale, acest caz a fost diagnosticat cu hipertiroidism congenital tranzitor- forma medie. Evoluţia a fost favorabilă. Particularitatea cazului a fost dată de asocierea semnelor de hipotiroidism si hipertiroidism, asocierea in evoluţie a atopiei, si persistenţa tahicardiei dupa normalizarea hormonală. Concluzii: Nou-născuţii din mame cu boală Graves-Basedow, prezintă risc de hipertiroidism congenital tranzitor, cel sever fiind mai frecvent întâlnit la cei ai căror mame au fost tratate cu iod radioactiv, sau chirurgical.tratamentul cu doze mari de antitiroidiene de sinteză în sarcină, creşte riscul hipotiroidismului perinatal tranzitor.necesitatea monitorizării pentru hipertiroidism, la nou-născuţii din mame cu Basedow, începe din perioada intrauterină şi până la 3-6 luni, iar ulterior, cazurile vor fi dispensarizate pentru riscul dezvoltării unei patologii autoimune. Fiind binecunoscută dinamica particulară de dezvoltare a copilului, problemele de diagnostic, monitorizarea şi tratamentul corect, necesită o bază de cunoştinţe de pediatrie, dublate de cele din alte specialităţi. În acest sens, colaborarea între endocrinologul de adulţi, obstetrician, neonatolog, pediatru (endocrinolog, cardiolog, neurolog) reprezintă cea mai bună soluţie pentru o evoluţie bună a acestor cazuri. Cuvinte cheie: nou-născut, hipertiroidism, monitorizare ABSTRACT Introduction: Fetal and neonatal hyperthyroidism is usually produced by transplacental passage of thyroid-stimulating immunoglobulins (TSI). Graves disease is by far the most common cause of neonatal hyperthyroidism.a small percentage of mothers with hyperthyroidism caused by Graves disease have neonates (or fetuses) with hyperthyroidism 1-5%. Although rare, it can be severe-depending, even life-threatening, and have deleterious effects on neural development. Objective: Underlining diagnosis problems and complications of an infant of mother with Graves hyperthyroidism. Material and methods: Case presentation of a 2 week old newborn admitted in our clinic for hyperkinesis, jaundice, poor weight gain. Based on clinical, paraclinical, immunological and hormonal exams, the diagnosis of neonatal transient hyperthyroidism of mother with Graves disease was established. Case particularity was defined by association of hypo- and hyperthyroidism, evolutive atopy and persistence of tachycardia after hormonal status normalization. Conclusions: Most commonly, TSI are a component of active maternal Graves disease. However, such antibodies may continue to be produced after ablation of the thyroid by surgery, radioiodine, inducing a severe form of neonatal hyperthyroidism. Treatment with high dosis of antithyroid drugs during pregnancy increases the risk of transient neonatal hypothyroidism. The follow-up for hyperthyroidism in newborns from mothers with Graves disease starts in the intrauterine period up to 3-6 months, cases needing to be verified afterwards, taking into account the risk of developing autoimmune pathology. Given the children s particular growth dynamics, the challenges in diagnosis, follow-up, and correct treatment require a wide amount of knowledge in pediatrics, as well as other fields. In this matter, collaboration between adult endocrinologists, obstetricians, neonathologists and endocrinepediatricians leads to best results in terms of evolution. Key Words: newborn, transient neonatal hyperthyroidism 1 Victor Babes University of Medicine and Pharmacy, Timisoara, 2 Louis Turcanu Emergency Children Hospital Pediatric Clinic, Timisoara Correspondence to: Prof. Ioana Micle, MD, PhD Dept of Pediatric Endocrinology, Louis Turcanu Emergency Children Hospital, 2 Iosif Nemoianu Str., Timişoara, Tel micleioana@yahoo.co.uk Received for publication: Apr. 06, Revised: Sep. 14, INTRODUCTION Graves disease and Hashimoto s thyroiditis represent the two most common autoimmune thyroid disorders during pregnancy affecting fetal and neonatal development. The immunological mechanisms involved in these diseases are closely related, the differences between the two disorders are made by antibody titre determination. High TSI levels are found in Basedow disease, while they are absent in Hashimoto. In Hashimoto, antibodies against Ioana Micle et al 357
2 thyroid peroxidase and/or thyroglobulin cause gradual destruction of cells in the thyroid gland. 1,2 The endocrine pathology of the newborn can seriously affect his health status and, not recognized and treated properly, can be life-threatening. Fetal hyperthyroidism may be associated with intrauterine growth retardation, nonimmune fetal hydrops, craniosynostosis and intrauterine death. Features of this condition in the neonate include hyperkinesis, diarrhoea, poor weight gain, vomiting, ophthalmopathy, cardiac failure and arrhythmias, systemic and pulmonary hypertension, hepatosplenomegaly, jaundice, hyperviscosity syndrome, thrombocytopenia, craniosynostosis and death in the severe form thyrotoxicosis. 3 Fetal and neonatal hyperthyroidism are usually produced by transplacental passage of TSI (80%). 1,3,4 Most commonly, TSI are a component of active maternal Graves disease. However, such antibodies may continue to be produced after ablation of the thyroid by surgery or radioiodine treatment. Other mechanisms that have produced fetal and neonatal hyperthyroidism include activating mutations of the stimulatory G protein in McCune-Albright syndrome and activating mutations of the thyrotropin (TSH) receptor nonautoimmune hyperthyroidism. 1,5-7 The incidence of neonatal Graves disease is 1 to 2 per 1,000 births from affected mothers. The cause for concern is that the infant mortality rate is 16% to 25%. 7,8 Cause of death could be heart failure and/or dyselectrolytemia produced by intestinal hyperperistaltism and diarrhoea. Remission by 20 weeks is most common in neonatal Graves disease; remission by 48 weeks is nearly always seen, due to clearance of maternal antibodies from the newborn circulation. The treatment for neonates is driven by the clinical symptoms and laboratory values. If the patient has obvious clinical symptoms (goiter, cardiac failure, exophtalmia) with significant TSH suppression, the infant should receive a beta blocker and an antithyroid drug. If the laboratory values show minimal changes and the patient has no obvious clinical symptoms and good growth, observation alone may be sufficient. Monthly follow-up, with laboratory evaluation, is recommended. 2,4,7 CASE REPORT The patient, P.A., 2 weeks old, male was admitted in our hospital for: hyperkinesis, poor weight gain, jaundice. During the 20 th week of gestation the mother was diagnosed with Graves disease. Thyamazol until 358 TMJ 2009, Vol. 59, No weeks of gestation was instituted, followed by Propilthyouracil. Immunological and hormonal monitoring during pregnancy had shown high TSI level: 18.8 IU/ml (Normal values < 2 IU/l), in the 31 st week of gestation. At delivery, TSI and TSH cord blood values were high (20 UI/l respectively µu/ml), and FT4 value (1.27 ng/ml) was in normal range. After 5 days, TSH value maintained high ( µu/ml) and FT4 normal (1.69 ng/ml). The pacient left maternity without clinical and hormonal follow-up recommendations. At the age of two weeks the newborn presented psychomotory agitation, growth retardation, jaundice reasons for hospital addmission. Birth history revealed the child s order of birth (second child), gestational age 39 weeks, birth weight 3250 g (50 percentile), length 50 cm (50 percentile), cranial circumference 34 cm (25 percentile), Apgar score 9, immunized with BCG and Engerix. Positive familial history was stated for endocrinological disease: maternal grandmother with Graves disease, mother diagnosed during pregnancy with the same disease. Table 1. Immunological and hormonal evaluation at 2 weeks. Hormones TSH ( µu/ml) FT4 ( ng/ml) Values µu/ml 2.31 ng/ml At the hospital addmision clinical examination revealed a newborn with gain loss from birth (3120g), pallor, jaundice, cutaneous trophic alterations, polipneea, tachycardia bpm; accelerated intestinal transit 7 stools/day, hiperexcitability, clonus, incomplete archaic reflexes. Biological and paraclinical findings were: low hemoglobin value (10.6 g/dl), red blood cells 2,990,000/mm3, hematocrit 31.1%, seric proteins 40 g/l, low serum iron level 8,2 µmol/l and high levels of unconjugated bilirubin (123 mmol/l) and lactic acid (24 mg%). Immunological and hormonal status at two weeks showed an increase in antibodies values: antithyroidperoxidase (TPO), antithyroglobulin (Tg) and TSI. (Table 1). Thyroid stimulating immunoglobulins were two-fold increased in maternal milk. Paraclinical investigations (EKG and Holter EKG) revealed the presence of sinusal tachycardia (heart rate up to 255 bpm). Cerebral ultrasonography demonstrated the aspect of diffuse hypoxic-ischemic
3 Table 2. Treatment, immunological and hormonal monitorization during pregnancy. 20 weeks gestation 31 weeks gestation 34 weeks gestation 38 weeks gestation FT4 ( ng/dl) 5.82 Ó FT3 ( pg/ml) TSH ( µu/ml) 0.002Ô 0.001Ô - - TSI ( < 2 IU/l) Mothers medication Thyrozol Propilthyouracil 40 mg/day 1month 20 mg/day 15 mg/day 150 mg/day encephalopathy with intraventricular hemorrhage. Electroencephalogram showed an irritative trace. After evaluation, the diagnosis was: Moderate transient congenital hyperthyroidism Carential anemia Hypoxic-ischemic encephalopathy Prolonged neonatal jaundice Treatment in this case was pathogenic and roborant: Phenobarbital for enzymatic induction (glucuronoconjugation); Pentoxiphyllin and Tanakan for circulatory modifications; betablocker for tachycardia; iron preparation for anemia, vitaminotherapy. At this time the child was mixed fed (adapted milk formula was introduced due to decrease in maternal lactation). At 6 weeks, weight and antropometric parameters were within the limits of normal growth. Pallor (based on hematological findings), peripheric circulation disfunction, high HR ( bpm during treatment with Atenolol) and lower limbs hypertonia were still present. Values for antibodies levels were lower: TPO (188 IU/ml), TSI (3.7 IU/ml). TSH and FT4 levels were normal (respectively 2.81 µu/ml and 1.26 ng/ ml). Holter EKG showed persistent sinusal tachicardia. Cerebral ultrasonography revealed the same aspect. At the age of three months, weight was 6000g (Pc- 75), cranial circumference 39 cm (Pc-25), length 62 cm (Pc-75). Skin was still pale, with atopic dermatitis on the face and skull. Heart rate was still bpm during treatment with Atenolol. Hypertonia preserved, while psychological acquisition was age-appropriate. Thyroid-stimulating immunoglobulin level was 0.1 IU/l and TPO antibodies dissapeared. Paraclinic investigations revealed sinusal tachicardia and discrete improvement of cerebral suffering. At this time the infant was entirely artificially-fed. DISCUSSION: Risks of an infant born from a mother with Graves disease are multiple, beginning in utero: - Mother s uncontrolled hyperthyroidism can lead to tachycardia, prematuriy, intrauterin growth retardation and possible malformations. 2,4,7 - Elevated levels of TSI cross the placenta, bound to TSH receptor, stimulate adenylcyclase, with AMPc overproduction, stimulating the fetal thyroid function. 1,2,4,5,8,9 Severe congenital hyperthyroidism caused by maternal TSI is rare, the antithyroidian treatment (used in pregnancy) having an important role. Antithyroidian medication crosses the placenta and has a protective effect against fetal thyroid hyperfunction. 3,7,10 Infants born to mother with Graves disease treated with radioactive iodine or by surgery, not requiring antithyroidian medication are at higher risk, developing severe hyperthyroidism due to antibodies persistence after thyroid function normalisation. 2,4,7,11 - Antithyroidian treatment, Methimazole or Propylthiouracil, crosses the placenta and can affect fetal thyroid function leading to hypothyroidism and sometimes goiter. Effect of the dose that leads to maternal hormone normalization is different for the fetus. Because of slower fetal hepatic metabolization of antithyroid drugs, fetal FT4 can be lower then maternal. Fetal TSH level can be elevated by feed-back regulation. 4,3,12,13 Coroborating these risks, the aim of treatment during pregnancy is to maintain maternal hormone level close to normal with a minimum dose of medication. In our case, the risk for thyrotoxicosis was present in the 31 st week of gestation (maternal TSI =18.8 IU/l). (Table 2). At this time, intrauterine fetal heart rate monitorization and fetal development are indispensable (no anamnestic data was obtained). High TSH level and normal FT4 level at birth and 5 days after in our case can be explained by a transient subclinical hypothyroidism determined by: - Transplacentar passage and fetal slow metabolism of antithyiroidian medication; 1,4 - Possible concomitent presence of inhibing (that inhibate adenylcyclase) or TSH binding antibodies. In 80% of patients with antireceptor TSH antibodies, they act like agonists and in 20% of cases they play an antagonist role. 2,7,11 Ioana Micle et al 359
4 Table 3. Immune and hormone evolution of the patient from birth to 3 months. Age Ombilical cord 5 th day of life 2 weeks 6 weeks 3 month anti TPO ( 0-12 IU/ml) anti TG ( 0-34 UI/ml) TSI < 2 UI/l Infant Ó 3.7 Ó 0.1 Maternal milk Ó - - FT4 N.V. = ng/ml TSH N.V. = µU/ml â Perinatal cerebral injury (illustrated by neurological signs, cerebral ultrasound and EEG), affecting pituitary-thyroid axis: anterior pituitary gland hypersecretion in a first phase and/or quick reduction of circulant T3 level with short term increasing of TSH. 7,14 TSH ombilical cord 26, Figure 1. Evolution of hormone 25, th day of life 2 weeks 6 weeks TSH ( 0,49-4,97 U/µU/ml) FT4 (0,71-1,85 ng/ml) ,81 3 months FT ,779 0 From the age of two weeks, thyroid stimulating antibodies led to an increased FT4 level with TSH downregulation; 6 weeks after birth, antibodies titre decreased followed by hormone normalization. (Table 3, Fig. 2) At the age of six weeks TPO antibodies titre decreased two-fold, and, at 3 months, there was no antibodies titre. Thyroid stimulating immunoglobulins evolution was also descendent. Presence of TSI in maternal milk were sett off rising questions about TSI s intestinal absorption and metabolization of the infant. (Table 3, Fig. 1) Clinical, hormonal and immunological monitorization in newborns from mothers with Graves disease is required to prevent possible complications starting from intrauterine period untill 3-6 months after birth. (Fig. 3) TSI TPO ombilical 2 w eeks 6 w eeks3 months cord TSI ( < 2 UI/l) Figure 2. Evolution of antibodies TPO (0-12 IU/ml) In the case presented above, the follow-up plan was initiated at the first admission in our clinic (at the age of 14 days). Further neurological and psychosomatic evaluation is required for preventing long term modifications. Genetic counseling is important, taking into account the risk of developing autoimmune pathology. Figure 3. Congenital hyperthyroidism monitorization Case particularity was defined by association of hypo- and hyperthyroidism, evolutive atopy and TMJ 2009, Vol. 59, No. 3-4
5 persistence of tachycardia after hormonal status normalization. Antiperoxidase antibodies, forming circulating immune complexes and participating in cytotoxic reactions, could play a role in damaging cardiac fibre by injuring the endothelium producing cardiac rhythm disturbances. 2,11,15 Presence of atopic dermatitis at the age of three months may be an association with another autoimmune pathology; time and further evaluation will or not confirm that aspect. 2,11,14 CONCLUSIONS Fetal and neonatal hyperthyroidisms are usually produced by transplacental passage of TSI. Most commonly, TSI are a component of active maternal Graves disease. However, such antibodies may continue to be produced after ablation of the thyroid by surgery, radioiodine, inducing a severe form of neonatal hyperthyroidism. Treatment with high doses of antithyroid drugs during pregnancy increases the risk of transient neonatal hypothyroidism. The follow-up for hyperthyroidism in newborns from mothers with Graves disease starts in the intrauterine period up to 3-6 months, cases needing to be verified afterwards, taking into account the risk of developing autoimmune pathology. Given the children s particular growth dynamics, the challenges in diagnosis, follow-up, and correct treatment require a wide amount of knowledge in pediatrics, as well as other fields. In this matter, collaboration between adult endocrinologists, obstetricians, neonathologists and endocrine pediatricians leads to best results in terms of evolution. ACKNOWLEDGEMENTS We are grateful to Mihaela Vlad, MD, from the Department of Endocrinology of Victor Babes University of Medicine and Pharmacy, Timisoara, for leading the patient into our Department of Pediatric Endocrinology. REFERENCES 1. Tataru-Abagiu M, Bistriceanu M, Popescu M, et al. Cercetarea evolutiei sub tratament a anticorpilor antitiroidieni la pacientii cu afectiuni autoimune tiroidiene. Rev Endocr Metab 2006;2: Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin of North America, 2000;29: Fuhrer D, Lewis MD, Alkhafaji F, et al. Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology 2003;144: DeGroot LJ.: Diagnosis and treatment of Graves disease, Thyroid and its Diseases, 2003;11: Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifyng hypothesis. Clin Endocrinol 2004;60(4): Brix TH, Hansen PS, Kyvik KO, et al. Agregation of thyroid autoantibodies in first-degree relatives of patients with autoimmune thyroid disease is mainly due to genes: a twin study. Clin Endocrinol, 2004,60,(3): Janet M. Rennie, N.R.C. Roberton. Textbook of Neonatology, Third Edition, Churchill Livingstone, 1999, p Wallaschofski H, Orda C, Georgi P, et al. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goitre. Horm Metab Res 2001;33: Schwarz-Lauer L, Chazenbalk G, McLachlan SM, et al. Evidence for a simplified view of autoantibody interactions with the TSH receptor. Thyroid 2002;12: Rapoport B, Chazenbalk GD, Jaume JC, et al. TSH receptor: interaction with TSH and autoantibodies. Endocr Rev 1998;19: Ludgate ME, Mazziotti G. Thyroid autoimmune disease. In: Neuroimmunoendocrinology (Chrousos G, Ed.). Marcel Dekker: New York, 2003, p Krude H, Biebermann H, Krohn HP, et al. Congenital hyperthyroidism. 45 th Meeting of the European Society for pediatric Endocrinology(ESPE) Rotterdam, The Netherlands, June 30-July 3, Marwaha RK, Sen S, Tandon N, et al. Familial aggregation of autoimmune thyroiditis in first-degree relatives of patients with juvenile autoimmune thyroid disease. Thyroid 2003;13: Vanhorebeek I, Langouche L, Van den Berghe G. Thyroid autoimmune diseease. Nature Clinical Practice Endocrinology and Metabolism Ian 2006;2(1): Leslie D, Lipsky P, Notkins AL. Autoantibodies as predictors of disease. J Clin Invest, 2001;108 (10): Ioana Micle et al 361
Lecture title. Name Family name Country
Lecture title Name Family name Country Nguyen Thy Khue, MD, PhD Department of Endocrinology HCMC University of Medicine and Pharmacy, MEDIC Clinic Hochiminh City, Viet Nam Provided no information regarding
More information4) Thyroid Gland Defects - Dr. Tara
4) Thyroid Gland Defects - Dr. Tara Thyroid Pituitary Axis TRH secreted in the hypothalamus stimulates production and Secretion of TSH TSH stimulates secretion of T3, T4 T4 has negative feedback on secretion
More informationClinical Guideline MANAGEMENT OF INFANTS BORN TO MOTHERS WITH GRAVES DISEASE AND AT RISK OF THYROTOXICOSIS
Clinical Guideline MANAGEMENT OF INFANTS BORN TO MOTHERS WITH GRAVES DISEASE AND AT RISK OF THYROTOXICOSIS Date of First Issue 18/07/2016 Approved 28/09/2017 Current Issue Date 16/06/2017 Review Date 01/09/2019
More informationBELIEVE MIDWIFERY SERVICES
TITLE: THYROID DISEASE IN PREGNANCY EFFECTIVE DATE: July, 2013 POLICY STATEMENT: Pregnancy changes significantly the values influenced by the serum thyroid binding hormone level (i.e., total thyroxine,
More informationThyroid gland defects. Dr. Tara Husain
Thyroid gland defects Dr. Tara Husain Thyroid Pituitary Axis TRH secreted in the hypothalamus stimulates production and Secretion of TSH TSH stimulates secretion of T3,T4 T4 has negative feed back on secretion
More informationThe Thyroid and Pregnancy OUTLINE OF DISCUSSION 3/19/10. Francis S. Greenspan March 19, Normal Physiology. 2.
The Thyroid and Pregnancy Francis S. Greenspan March 19, 2010 OUTLINE OF DISCUSSION 1. Normal Physiology 2. Hypothyroidism 3. Hyperthyroidism 4. Thyroid Nodules and Cancer NORMAL PHYSIOLOGY Iodine Requirements:
More informationScreening Babies at risk of Congenital Hyperthyroidism GL354
1 Screening Babies at risk of Congenital Hyperthyroidism GL354 Approval and Authorisation Approved by Job Title Date Paediatric Clinical Governance Chair of paediatric Clinical Governance March 2016 Change
More informationHyperthyroidism Diagnosis and Treatment. April Janet A. Schlechte, M.D.
Hyperthyroidism Diagnosis and Treatment Family Practice Refresher Course April 2015 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any
More informationNeonatal Thyrotoxicosis Management of babies born to mothers with a history of hyperthyroidism (Grave s Disease)
MCN for Neonatology West of Scotland Neonatal Guideline Neonatal Thyrotoxicosis Management of babies born to mothers with a history of hyperthyroidism (Grave s Disease) This document is applicable to all
More informationSlide notes: This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications,
1 This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications, including ophthalmic complications, treatments (both permanent solutions
More informationNEWBORN FEMALE WITH GOITER PAYAL PATEL, M.D. PEDIATRIC ENDOCRINOLOGY FELLOW FEBRUARY 12, 2015
NEWBORN FEMALE WITH GOITER PAYAL PATEL, M.D. PEDIATRIC ENDOCRINOLOGY FELLOW FEBRUARY 12, 2015 CHIEF COMPLAINT 35 6/7 week F with goiter, born to a mother with Graves disease (GD) HPI 35 6/7 week F born
More informationThe Number Games and Thyroid Function Arshia Panahloo Consultant Endocrinologist St George s Hospital
The Number Games and Thyroid Function Arshia Panahloo Consultant Endocrinologist St George s Hospital Presentation Today: Common thyroid problems and treatments Pregnancy related thyroid problems The suppressed
More informationThyroid disorders. Dr Enas Abusalim
Thyroid disorders Dr Enas Abusalim Thyroid physiology The hypothalamic pituitary thyroid axis And peripheral conversion of T4 to T3, WHERE, AND BY WHAT ENZYME?? Only relatively small concentrations of
More informationThyroid Function TSH Analyte Information
Thyroid Function TSH Analyte Information 1 2013-05-01 Thyroid-stimulating hormone (TSH) Introduction Thyroid-stimulating hormone (thyrotropin, TSH) is a glycoprotein with molecular weight of approximately
More informationHYPERTHYROIDISM. Hypothalamus. Thyrotropin-releasing hormone (TRH) Anterior pituitary gland. Thyroid-stimulating hormone (TSH) Thyroid gland T4, T3
HYPERTHYROIDISM Hypothalamus Thyrotropin-releasing hormone (TRH) Anterior pituitary gland Thyroid-stimulating hormone (TSH) Thyroid gland T4, T3 In hyperthyroidism, there is an increased production of
More informationThyrotoxicosis in Pregnancy: Diagnose and Management
Thyrotoxicosis in Pregnancy: Diagnose and Management Yuanita Asri Langi email: meralday@yahoo.co.id Endocrinology & Metabolic Division, Internal Medicine Department, Prof.dr.R.D. Kandou Hospital/ Sam Ratulangi
More informationNone. Thyroid Potpourri for the Primary Care Physician. Evaluating Thyroid Function. Disclosures. Learning Objectives
Thyroid Potpourri for the Primary Care Physician Ramya Vedula DO, MPH, ECNU Endocrinology, Diabetes and Metabolism Princeton Medical Group Assistant Professor of Clinical Medicine Rutgers Robert Wood Johnson
More informationTHYROID DISEASE IN CHILDREN
THYROID DISEASE IN CHILDREN Michelle Schweiger, D.O. Center for Pediatric and Adolescent Endocrinology Cleveland Clinic Foundation Neither I nor any immediate family members have any financial interests
More informationINFANT OF A MOTHER WITH GRAVES DISEASE. Endorama May 14 th, 2015 Carmen Mironovici, M.D.
INFANT OF A MOTHER WITH GRAVES DISEASE Endorama May 14 th, 2015 Carmen Mironovici, M.D. Chief Complaint Newborn born to a mother with autoimmune hyperthyroidism HPI Male infant born at 39w 2d gestation
More informationApproach to thyroid dysfunction
Approach to thyroid dysfunction Alice Y.Y. Cheng, MD, FRCPC Twitter: @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or
More informationThyroid and Antithyroid Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine April 2014
Thyroid and Antithyroid Drugs Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine April 2014 Anatomy and histology of the thyroid gland Located in neck adjacent to the 5 th cervical vertebra (C5). Composed
More informationA RARE CASE OF THYROTOXICOSIS IN PEDIATRIC PRACTICE
Original Case Report DOI - 10.26479/2016.0204.13 A RARE CASE OF THYROTOXICOSIS IN PEDIATRIC PRACTICE Renata Markosyan 1,2, Natalya Volevodz 3,4, Lusine Navasardyan 1,2 and Karmella Pogosyan 2 1.Yerevan
More informationThyroid Disease in Pregnancy. Justin Moore, MD
Thyroid Disease in Pregnancy Justin Moore, MD Case 1 22 yr old G1P0 female at 14 2/7 weeks presents with tremor Weight stable since first positive pregnancy test Some nausea, rare vomiting TSH 0.02 miu/l,
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy Early diagnosis and good management of maternal thyroid dysfunction are essential to ensure minimal adverse effects on
More informationHYPOTHYROIDISM AND HYPERTHYROIDISM
HYPOTHYROIDISM AND HYPERTHYROIDISM SHAHIDA PERVEEN, AMBREEN Post RN BSCN Semester II FACULTY SIR RAJA April 13, 016 Objectives: State the functions of thyroid hormone. Understand the pathologic mechanism
More informationHyperthyroidism. Objectives. Clinical Manifestations. Slide 1. Slide 2. Slide 3. Implications for Primary Care. hyperthyroidism
1 Hyperthyroidism Implications for Primary Care Laura A. Ruby, DNP, CRNP Wellspan Endocrinology 2 Objectives! Discuss the clinical manifestations of hyperthyroidism! Review the use of the diagnostic studies!
More informationB-Resistance to the action of hormones, Hormone resistance characterized by receptor mediated, postreceptor.
Disorders of the endocrine system 38 Disorders of endocrine system mainly are caused by: A-Deficiency or an excess of a single hormone or several hormones: - deficiency :can be congenital or acquired.
More information344 Thyroid Disorders
344 Thyroid Disorders Definition/Cut-Off Value Thyroid dysfunctions that occur in pregnant and postpartum women, during fetal development, and in childhood are caused by the abnormal secretion of thyroid
More informationDIAGNOSTIC APPROACH TO GOITER IN CHILDREN
DIAGNOSTIC APPROACH TO GOITER IN CHILDREN Ramona Stroescu 1,2, Teofana Bizerea 1,2, Daniela Chiru 1,2, Tamara Marcovici 1,2, Giorgiana Brad 1,2, Oana Belei 1,2, Laura Olariu 1,2, Otilia Mărginean 1,2 Abstract
More informationThyroid Function. Thyroid Antibodies. Analyte Information
Thyroid Function Thyroid Antibodies Analyte Information - 1-2013-04-30 Thyroid Antibodies Determination of thyroid autoantibodies are, besides TSH and FT4, one of the most important diagnostic parameters.
More informationPregnancy & Thyroid. Zohreh Moosavi Associate professor of Endocriology Imam Reza General Hospital Mashad University. Imam Reza weeky Conferance
Pregnancy & Thyroid Zohreh Moosavi Associate professor of Endocriology Imam Reza General Hospital Mashad University Imam Reza weeky Conferance Objectives Thyroid Disorders & Pregnancy Normal thyroid phsyiology
More informationUpdate on Gestational Thyroid Disease. Aidan McElduff The Discipline of Medicine, The University of Sydney
IADPSG 2016 Update on Gestational Thyroid Disease Aidan McElduff The Discipline of Medicine, The University of Sydney IADPSG 2016 DISCLOSURES and AIM Nil to disclose Aim: to provide an overview 2017 Guidelines
More information03-Dec-17. Thyroid Disorders GOITRE. Grossly enlarged thyroid - in hypothyroidism in hyperthyroidism - production of anatomical symptoms
Thyroid Disorders GOITRE Grossly enlarged thyroid - in hypothyroidism in hyperthyroidism - production of anatomical symptoms 1 Physiological Goiter load on thyroid supply of I - limited stress due to:
More informationChapter I.A.1: Thyroid Evaluation Laboratory Testing
Chapter I.A.1: Thyroid Evaluation Laboratory Testing Jennifer L. Poehls, MD and Rebecca S. Sippel, MD, FACS THYROID FUNCTION TESTS Overview Thyroid-stimulating hormone (TSH) is produced by the anterior
More informationThyroid Disorders Towards a Healthy Endocrine System
Thyroid Disorders Towards a Healthy Endocrine System What are Thyroid Disorders? The thyroid is a butterfly-shaped gland in the middle of the lower neck. Through the release of hormones, the thyroid regulates
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationToxic MNG Thyroiditis 5-15
Hyperthyroidism Facts Prevalence 0.5-1.0%, more common in women Thyrotoxicosis is excess thyroid hormones from endogenous or exogenous sources Hyperthyroidism is excess thyroid hormones from thyroid gland
More informationHypothyroidism in pregnancy. Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah
Hypothyroidism in pregnancy Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah Agenda 1. Epidemiology and clinical characteristics of maternal hypothyroidism 2. Prevention and
More informationDiseases of thyroid & parathyroid glands (1 of 2)
Diseases of thyroid & parathyroid glands (1 of 2) Thyroid diseases Thyrotoxicosis Hypothyroidism Thyroiditis Graves disease Goiters Neoplasms Chronic Lymphocytic (Hashimoto) Thyroiditis Subacute Granulomatous
More informationReview Article Management of Hyperthyroidism in Pregnancy: Comparison of Recommendations of American Thyroid Association and Endocrine Society
Thyroid Research Volume 2013, Article ID 878467, 6 pages http://dx.doi.org/10.1155/2013/878467 Review Article Management of Hyperthyroidism in Pregnancy: Comparison of of American Thyroid Association and
More informationTapazole Methimazole Tablets, USP DESCRIPTION
Tapazole Methimazole Tablets, USP DESCRIPTION TAPAZOLE (Methimazole Tablets, USP) (1-methylimidazole-2-thiol) is a white, crystalline substance that is freely soluble in water. It differs chemically from
More informationImaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist
Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging Deepa R Biyyam, MD Attending Pediatric Radiologist Imaging in Pediatric Thyroid disorders: Imaging modalities Outline ACR-SNM-SPR guidelines
More informationSanjay B. Dixit, M.D. BHS Endocrinology Associates November 11, 2017
Sanjay B. Dixit, M.D. BHS Endocrinology Associates November 11, 2017 I will not be discussing this Outline of discussion Laboratory tests for thyroid function Diagnosis of hypothyroidism Treatment of
More informationDAGNOSIS AND TREATMENT OF THYROID GLAND DISEASES IN PREGNANCY GUIDELINE AND RECOMMENDATIONS
Svetlana Spremovic-Radjenovic 1 DAGNOSIS AND TREATMENT OF THYROID GLAND DISEASES IN PREGNANCY GUIDELINE AND RECOMMENDATIONS The field referred to thyroid gland diseases and pregnancy has recorded the fast
More informationUnderstanding Thyroid Labs
Understanding Thyroid Labs Chris Sadler, MA, PA-C, CDE, DFAAPA Senior Medical Science Liaison CVM Janssen Scientific Affairs Diabetes and Endocrine Associates La Jolla, CA Disclosures Employee of Janssen
More informationCongenital hypothyroidism and your child
Congenital hypothyroidism and your child Contributed by Sirisha Kusuma. B Consultant Pediatric Endocrinologist Rainbow Children s hospital What is Thyroid? The thyroid is a small butterfly shaped endocrine
More informationElectroencephalography (EEG) alteration in Autism Spectum Disorder (ASD)
Electroencephalography (EEG) alteration in Autism Spectum Disorder (ASD) FLORINA RAD 1, CAMELIA CIOBANU 2, GIANINA ANGHEL 3, IULIANA DOBRESCU 4 ABSTRACT There is a controversial relationship between Autism
More informationGrave s disease (1 0 )
THYROID DYSFUNCTION Grave s disease (1 0 ) Autoimmune - activating AB s to TSH receptor High concentrations of circulating thyroid hormones Weight loss, tachycardia, tiredness Diffuse goitre - TSH stimulating
More informationChecking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing
Checking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing Jean-Pierre Chanoine, MD Endocrinology and Diabetes Unit British Columbia s Children s Hospital Objectives 1. Interpret the
More informationWit JM, Ranke MB, Kelnar CJH (eds): ESPE classification of paediatric endocrine diagnosis. 7. Thyroid disorders. Horm Res 2007;68(suppl 2):44 47
Wit JM, Ranke MB, Kelnar CJH (eds): ESPE classification of paediatric endocrine diagnosis. 7. Thyroid disorders. Horm Res 2007;68(suppl 2):44 47 ESPE Code Diagnosis OMIM ICD10 7 THYROID DISORDERS 7A HYPOTHYROIDISM
More informationHyperthyroidism and Hypothyroidism in Pregnancy Guideline
Aneurin Bevan University Health Board Hyperthyroidism and Hypothyroidism in Pregnancy Guideline N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed
More informationManagement of Fetal and Neonatal Graves Disease
HORMONE RESEARCH IN PÆDIATRIC S Mini Review Received: September 16, 2016 Accepted: November 3, 2016 Published online: December 16, 2016 Management of Fetal and Neonatal Graves Disease Juliane Léger Service
More informationTHYROID DISEASE IN PREGNANCY
THYROID DISEASE IN PREGNANCY https://www.wddty.com/magazine/2016/june/depression-its-not-your-brain-its-your-thyroid.html Grand Rounds December 5, 2018 Maria Kolojeski, DO (PGY3) REVIEW OF THYROID HORMONES
More informationDecoding Your Thyroid Tests and Results
Decoding Your Thyroid Tests and Results Wondering about your thyroid test results? Learn about each test and what low, optimal, and high results may mean so you can work with your doctor to choose appropriate
More informationEndocrine part two. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part two Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Cushing's disease: increased secretion of adrenocorticotropic
More informationEsther Briganti. Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy. Endocrinologist and Clinician Researcher
Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy Esther Briganti Endocrinologist and Clinician Researcher Director, Melbourne Endocrine Associates Associate Professor,
More informationThe interpretation and management of thyroid disorders
Journal of Endocrinology, Metabolism and Diabetes of South Africa 2015 ; 20(2) http://dx.doi.org/10.1080/16089677.2015.1056468 Open Access article distributed under the terms of the Creative Commons License
More informationTHE PHARMA INNOVATION - JOURNAL Assessment of Antithyroperoxidase Antibodies and Thyroid Hormones Among Sudanese Pregnant Women
Received: 01-09-2013 Accepted: 30-09-2013 ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 2 No. 9 2013 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION
More informationDRUGS. 4- Two molecules of DIT combine within the thyroglobulinto form L-thyroxine (T4)' One molecule of MIT & one molecule of DIT combine to form T3
THYROID HORMONEs & ANTITHYROID The thyroid secretes 2 types of hormones: DRUGS 1- Iodine containing amino acids (are important for growth, development and metabolism) and these are: triodothyronine, tetraiodothyronine,(
More informationTANJA KEMP INTERNAL MEDICINE: ENDOCRINOLOGY
ENDOCRINE DISORDERS IN THE ELDERLY (part 2) TANJA KEMP INTERNAL MEDICINE: ENDOCRINOLOGY Pituitary axis Target organs of the pituitary gland Negative feedback Hypothalamus-Pituitary-Thyroid axis Thyroid
More informationSTRANGE THYROID FUNCTION TESTS: REAL PATHOLOGY OR BIOLOGICAL PITFALL? Agnès Burniat, MD, PhD
STRANGE THYROID FUNCTION TESTS: REAL PATHOLOGY OR BIOLOGICAL PITFALL? Agnès Burniat, MD, PhD Concordant thyroid tests: respecting the hypothalamus-pituitarythyroid axis regulation Discordant thyroid tests:
More informationThyroid Disease in Pregnancy: The Essentials. Elizabeth N. Pearce, MD, MSc
Thyroid Disease in Pregnancy: The Essentials Elizabeth N. Pearce, MD, MSc None Disclosures Case 1 A 31-year-old woman from Massachusetts is practicing a vegan diet. She is currently planning a pregnancy.
More informationAlvin C. Powers, M.D. 1/27/06
Thyroid Histology Follicular Cells ECF side Apical lumen Thyroid Follicles -200-400 um Parafollicular or C-cells Colloid Photos from University of Manchester and tutorial created by Dr. James Crimando,
More informationHypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC
Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC Objectives 1. Define Hypoxic-Ischemic Encephalopathy (HIE) 2. Identify the criteria used to determine if an infant qualifies for therapeutic
More informationCase Report Methimazole Associated Neutropenia in a Preterm Neonate Treated for Hyperthyroidism
Case Reports in Endocrinology Volume 2015, Article ID 680191, 5 pages http://dx.doi.org/10.1155/2015/680191 Case Report Methimazole Associated Neutropenia in a Preterm Neonate Treated for Hyperthyroidism
More informationTimothy Bilash MD MS OBG Northern Inyo Hospital, Bishop, CA October 20, :30 PM
Thyroxine Deficiency in Pregnancy Timothy Bilash MD MS OBG Northern Inyo Hospital, Bishop, CA October 20, 2006 1:30 PM WHI Estrogen recap In http://courses.washington.edu/bonephys/opestrogen.html. from:
More informationsupraventricular (ectopic atrial) tachycardia: case report and review of the literature
Letter to the Editor Amiodarone-induced thyrotoxicosis with paroxysmal supraventricular (ectopic atrial) tachycardia: case report and review of the literature Zofia Kolesińska 1#, Katarzyna Siuda 1##,
More informationLABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS
LABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS Maryam Tohidi Anatomical & clinical pathologist Research Institute for Endocrine Sciences THYROID GLAND (15-25 gr), (12-20 gr), 2 lobes connected by
More informationUpdate on Thyroid Disorders Unrestricted Siemens Healthcare Diagnostics Inc All rights reserved.
Linda Rogers, PhD, DABCC, FACB Update on Thyroid Disorders Objectives 1. Define hypothyroidism and hyperthyroidism and describe the common clinical presentations and the general laboratory diagnosis of
More informationPathophysiology of Thyroid Disorders. PHCL 415 Hadeel Alkofide April 2010
Pathophysiology of Thyroid Disorders PHCL 415 Hadeel Alkofide April 2010 1 Learning Objectives Understand the pathophysiology of hyperthyroidism & hypothyroidism Describe the signs & symptoms of hyperthyroidism
More informationThyroid Hormones (T 4 & T 3 )
1 Thyroid Hormones (T 4 & T 3 ) Normalize growth and development, body temperature, and energy levels. Used as thyroid replacement therapy in hypothyroidism. Thyroxine (T 4 ) is peripherally metabolized
More informationAnalysis of Lag Behind Thyrotropin State After Radioiodine Therapy in Hyperthyroid Patients
Analysis of Lag Behind Thyrotropin State After Radioiodine Therapy in Hyperthyroid Patients ORIGINAL ARTICLE Mohshi Um Mokaddema, Fatima Begum, Simoon Salekin, Tanzina Naushin, Sharmin Quddus, Nabeel Fahmi
More informationDisorders of Thyroid Function
Disorders of Thyroid Function Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Thyroid Hormone Axis Hypothalamus TRH
More informationCase 1: 24 yo pregnant female presenting with abnormal TFTs and tachycardia RAJESH JAIN ENDORAMA 3/16/2017
Case 1: 24 yo pregnant female presenting with abnormal TFTs and tachycardia RAJESH JAIN ENDORAMA 3/16/2017 Chief Complaint The ER calls about a 24 year old, 12 weeks pregnant. She presented with tachycardia
More informationPhysiological processes controlled by hormones?
: the study of hormones, their receptors, the intracellular signaling pathways they invoke, and the diseases and conditions associated with them. What are hormones? Major endocrine glands? Fig 7-2 Physiological
More informationSample Type - Serum Result Reference Range Units. Central Thyroid Regulation Surrey & Activity KT3 4Q. Peripheral Thyroid D Function mark
Thyroid Plus Sample Type - Serum Result Reference Range Units Central Thyroid Regulation Surrey & Activity KT3 4Q Total Thyroxine (T4)
More informationDisclosures. Learning objectives. Case 1A. Autoimmune Thyroid Disease: Medical and Surgical Issues. I have nothing to disclose.
Disclosures Autoimmune Thyroid Disease: Medical and Surgical Issues I have nothing to disclose. Chrysoula Dosiou, MD, MS Clinical Assistant Professor Division of Endocrinology Stanford University School
More informationLaura Trask, MD FACP Central Maine Endocrinology Lewiston, ME
Laura Trask, MD FACP Central Maine Endocrinology Lewiston, ME 795-7520 traskla@cmhc.org No disclosures Objectives To have an understanding of hyperthyroidism To have an understanding of the management
More informationDISORDERS OF THE THYROID GLAND SIGNS, SYMPTOMS, & TREATMENT ENDOCRINE SYSTEM AT A GLANCE OBJECTIVES ANATOMY OF THE THYROID
OBJECTIVES DISORDERS OF THE THYROID GLAND SIGNS, SYMPTOMS, & TREATMENT Stephanie Blackburn, MHS, MLS(ASCP) CM LSU Health Shreveport Clinical Laboratory Science Program Discuss the synthesis and action
More informationClinical, Endocrinological and Immunological Characteristics of Japanese Patients With Autoimmune Polyglandular Syndrome Type 3a
Elmer ress Original Article J Endocrinol Metab. 2016;6(2):46-51 Clinical, Endocrinological and Immunological Characteristics of Japanese Patients With Autoimmune Polyglandular Syndrome Type 3a Sumie Moriyama
More informationWales Neonatal Network Guideline
Management of Neonates Born To Mothers with Thyroid Disease Maternal Hypothyroidism The prevalence of hypothyroidism during pregnancy is 0.3-0.5% for overt hypothyroidism, with raised Thyroid Stimulating
More informationIntra-amniotic thyroxine to treat fetal goiter
Case Report Obstet Gynecol Sci 2016;59(1):66-70 http://dx.doi.org/10.5468/ogs.2016.59.1.66 pissn 2287-8572 eissn 2287-8580 Intra-amniotic thyroxine to treat fetal goiter Min-Jung Kim 1, Yong-Hwa Chae 2,
More informationThyroid Gland 甲状腺. Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C541, Block C, Research Building, School of Medicine Tel:
Thyroid Gland 甲状腺 Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C541, Block C, Research Building, School of Medicine Tel: 88208292 Outline Thyroid Hormones Types Biosynthesis Storage and Release
More informationLectures 4 Early fetal assessment, screening, ultrasound and treatment modalities during pregnancy. II. Asphyxia and Resuscitation (3 lectures)...
Outline of a 2 year Neonatology educational course (80 lectures) PLUS 2 graduate level courses (GENETICS and BIOSTATISTICS & EPIDEMIOLOGY Approximate Percent in Examination I. Maternal-Fetal Medicine (6
More informationHORMONES OF THE POSTERIOR PITUITARY
HORMONES OF THE POSTERIOR PITUITARY HORMONES OF THE POSTERIOR PITUITARY In contrast to the hormones of the anterior lobe of the pituitary, those of the posterior lobe, vasopressin and oxytocin, are not
More informationLimits of Liability/Disclaimer of Warranty
Page 0 of 8 Limits of Liability/Disclaimer of Warranty The author, Brad Shook has made their best effort to produce a high quality and informative reference. The author makes no representation or warranties
More informationObjectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy
Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationTHE THYROID GLAND AND YOUR HEALTH
THE THYROID GLAND AND YOUR HEALTH Your Thyroid is a gland located at the base of your neck, just below your Adam s apple. It is shaped like a butterfly each wing or lobe, of your thyroid lies on either
More informationVI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology The most common forms of hyperthyroidism include Graves disease, Plummer disease, and toxic adenoma; but approximately 1-2% of
More informationHyperthyroïdie et Grossesse
Club Thyroïde, Paris 9 juin 2018 Hyperthyroïdie et Grossesse De la Mère à l Enfant Professeur Juliane Léger Endocrinologie diabétologie Pédiatrique Centre de Référence des Maladies Endocriniennes de la
More informationThe Presence of Thyroid Autoantibodies in Pregnancy
The Presence of Thyroid Autoantibodies in Pregnancy Dr. O Sullivan does not have any financial relationships with any commercial interests. KATIE O SULLIVAN, MD FELLOW, ADULT/PEDIATRIC ENDOCRINOLOGY ENDORAMA
More informationOUTLINE. Regulation of Thyroid Hormone Production Common Tests to Evaluate the Thyroid Hyperthyroidism - Graves disease, toxic nodules, thyroiditis
THYROID DISEASE OUTLINE Regulation of Thyroid Hormone Production Common Tests to Evaluate the Thyroid Hyperthyroidism - Graves disease, toxic nodules, thyroiditis OUTLINE Hypothyroidism - Hashimoto s thyroiditis,
More informationThyroid Disorders. Hypothyroidism. Low Total T4 Antiseizure meds Glucocorticoids. Free T4. Howard J. Sachs, MD.
Thyroid Disorders Free T4 Low Total T4 Antiseizure meds Glucocorticoids Hypothyroidism Howard J. Sachs, MD www.12daysinmarch.com Primary Hypothyroidism High TSH Low free T4 Primary = End organ failure
More informationHYPOTHYROIDISM IN CHILDREN. IAP UG Teaching slides
HYPOTHYROIDISM IN CHILDREN 1 OBJECTIVES Introduction Congenital hypothyroidism Etiology, clinical features, diagnosis, approach, treatment and prognosis Acquired hypothyroidism Etiology, clinical features,
More informationThyroid and Antithyroid Drugs. Dr. Alia Shatanawi Feb,
Thyroid and Antithyroid Drugs Dr. Alia Shatanawi Feb, 24 2014 Anatomy and histology of the thyroid gland Located in neck adjacent to the 5 th cervical vertebra (C5). Composed of epithelial cells which
More informationUpdate In Hyperthyroidism
Update In Hyperthyroidism CME Away India & Sri Lanka March 23 - April 7, 2018 Richard A. Bebb MD, ABIM, FRCPC Consultant Endocrinologist Medical Subspecialty Institute Cleveland Clinic Abu Dhabi Copyright
More informationCécile Brachet Endocrinologie Pédiatrique Hôpital Universitaire des Enfants Reine Fabiola U.L.B. Bruxelles
Des effets secondaires de l Iso Bétadine (PVP-I) chez le foetus et le nouveau-né via un traitement maternel à l accouchement Neonatal side Effects of povidone-iodine disinfection of pregnant or lactating
More informationGraves Disease in Pediatrics
Graves Disease in Pediatrics Graves disease is a common cause of an overactive thyroid. It occurs in about 1 in 5000 children and teens. It occurs more often in females than males. This booklet is designed
More informationPLACE OF SELENIUM IN THE TREATMENT OF THYROID DISEASES
VII, 2013, 2 27, PLACE OF SELENIUM IN THE TREATMENT OF THYROID DISEASES D. Gavrailova Faculty of Public Health, Medical University So a : (Se).,. Se, - (, )., Se., Se -. :,,, :,, Summary: The essential
More informationClinical evaluation Jaundice skin and mucous membranes
JAUNDICE Framework The definition of Neonatal Jaundice Billirubin Metabolism Special characteristic in neonates Dangerous of the Hyperbillirubinemia The diseases in relation with Neonatal Jaundice Objectives:
More information